Global Leflunomide Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 118 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Leflunomide (original brand name Arava) is an immunosuppressive disease-modifying antirheumatic drug (DMARD), used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor that works by inhibiting dihydroorotate dehydrogenase.

This report provides detailed analysis of worldwide markets for Leflunomide from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Leflunomide market and further lays out an analysis of the factors influencing the supply/demand for Leflunomide, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Leflunomide Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Leflunomide market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Leflunomide market are Cipla (India), Aarti Drugs (India), Orbit Lifescience (India), Formosa Laboratories (Taiwan), Cinkate (China), Huitian Bio-Pharma (China), Yabang Pharmaceutical (China), Merro (China), Longlife Group (China), WATSON (Changzhou) (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Leflunomide industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Leflunomide Production Volume (Unit) 2011-2016
Figure Global Leflunomide Production Value (M USD) 2011-2016
Figure Top 10 Leflunomide Vendors Production Volume Share 2015
Figure Top 10 Leflunomide Vendors Production Value Share 2015
Figure Regional Leflunomide Production (Unit) 2015
Figure Regional Leflunomide Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Leflunomide Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Leflunomide Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Leflunomide Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Leflunomide Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Leflunomide Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Leflunomide Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Leflunomide Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Leflunomide Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Leflunomide Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Leflunomide Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Leflunomide Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Leflunomide Vendors Production (Unit) 2011-2016
Table Global Key Leflunomide Vendors Production Share 2011-2016
Figure Global Leflunomide Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Leflunomide Vendors Production (Unit) 2011-2016
Table Global Top 10 Leflunomide Vendors Production (Unit) 2011
Table Global Top 10 Leflunomide Vendors Production (Unit) 2012
Table Global Top 10 Leflunomide Vendors Production (Unit) 2013
Table Global Top 10 Leflunomide Vendors Production (Unit) 2014
Table Global Top 10 Leflunomide Vendors Production (Unit) 2015
Table Global Top 10 Leflunomide Vendors Production (Unit) 2016
Figure Leflunomide Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Leflunomide Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Leflunomide Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Leflunomide Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Leflunomide Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Leflunomide Production Value (M USD), Growth Rate
Table Global Key Leflunomide Vendors Production Value (M USD) 2011-2016
Table Global Key Leflunomide Vendors Production Value Share 2011-2016
Figure Global Top 10 Leflunomide Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2011
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2012
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2013
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2014
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2015
Table Global Top 10 Leflunomide Vendors Production Value (M USD) 2016
Figure Leflunomide Prices (USD/Ton) 2016
Figure Leflunomide Gross Margin 2016
Figure Leflunomide Production Value (M USD) By Region 2011-2016
Table Global Leflunomide Production Value (M USD) 2011-2016
Table Global Leflunomide Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Leflunomide Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Leflunomide Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Leflunomide Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Leflunomide Production Value Share Trend
Figure Global Leflunomide Consumption Volume (Unit) 2015
Table Regional Leflunomide Consumption Volume (Unit) 2011-2016
Table Regional Leflunomide Consumption Volume Share 2011-2016
Figure Leflunomide Consumption in North America 2011-2016
Figure Leflunomide Consumption in EMEA 2011-2016
Figure Leflunomide Consumption in Asia-Pacific 2011-2016
Figure Leflunomide Consumption in ROW 2011-2016
Figure Global Leflunomide Consumption Volume (Unit) 2016
Table Global Leflunomide Consumption Volume (Unit) 2011-2016
Table Global Leflunomide Consumption Volume Share 2011-2016
Figure Global Leflunomide Production (Unit) Forecast 2016-2021
Table Global Leflunomide Production (Unit) 2016-2021
Table Global Leflunomide Production Share 2016-2021
Figure North Leflunomide Production (Unit) Forecast 2016-2021
Figure EMEA Leflunomide Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Leflunomide Production (Unit) Forecast 2016-2021
Figure ROW Leflunomide Production (Unit) Forecast 2016-2021
Figure Global Leflunomide Revenue (M USD) Forecast 2016-2021
Table Global Leflunomide Revenue (M USD) 2016-2021
Table Global Leflunomide Revenue Share 2016-2021
Figure North America Leflunomide Revenue (M USD) Forecast 2016-2021
Figure EMEA Leflunomide Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Leflunomide Revenue (M USD) Forecast 2016-2021
Figure ROW Leflunomide Revenue (M USD) Forecast 2016-2021
Figure Global Leflunomide Consumption Volume (Unit) 2016-2021
Table Global Leflunomide Consumption Volume (Unit) 2016-2021
Table Global Leflunomide Consumption Volume Share 2016-2021
Figure North America Leflunomide Consumption (Unit) Forecast
Figure EMEA Leflunomide Consumption (Unit) Forecast
Figure Asia-Pacific Leflunomide Consumption (Unit) Forecast
Figure ROW Leflunomide Consumption (Unit) Forecast
Figure Global Leflunomide Consumption Volume (Unit) 2021
Table Global Leflunomide Consumption Volume (Unit) 2016-2021
Table Global Leflunomide Consumption Volume Share 2016-2021
Table Key Strategies for Leflunomide Multinational Corporations
Table Key Strategies for Leflunomide Emerging-Market Players